| Literature DB >> 26886325 |
Geoffrey Tucker1, Binodh DeSilva2, Jennifer Dressman3, Michiho Ito4, Takuya Kumamoto5, Don Mager6, Hanns-Christian Mahler7, Anke H Maitland-van der Zee8, Giovanni M Pauletti9, Hitoshi Sasaki10, Vinod Shah11, Daniel Tang12, Michael Ward13.
Abstract
The chairs of each of the 8 Special Interest Groups of the Board of Pharmaceutical Sciences of the International Pharmaceutical Federation have compiled opinions with regard to major challenges for the pharmaceutical sciences over the next 5-10 years. Areas covered are drug design and discovery, natural products, formulation design and pharmaceutical technology, pharmacokinetics/pharmacodynamics and systems pharmacology, translational and personalized medicine, biotechnology, analytical sciences and quality control, and regulatory science.Entities:
Keywords: analytical chemistry; bioequivalence; biotechnology; drug design; materials science; natural products; pharmacodynamics; pharmacogenetics; pharmacokinetics
Mesh：
Substances：
Year: 2016 PMID： 26886325 DOI： 10.1016/j.xphs.2015.12.001
Source DB: PubMed Journal: J Pharm Sci ISSN： 0022-3549 Impact factor: 3.534